Literature DB >> 33980667

The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review.

Charlie McLeod1,2,3, Jamie Wood4, Allison Tong5,6, André Schultz7,8, Richard Norman9, Sherie Smith10, Christopher C Blyth11,2,3,12, Steve Webb13,14, Alan R Smyth10, Thomas L Snelling5,15.   

Abstract

There is no consensus on how best to measure responses to interventions among children and adults with cystic fibrosis (CF). We have systematically reviewed and summarised the characteristics and measurement properties of tests and tools that have been used to capture outcomes in studies among people with CF, including their reliability, validity and responsiveness. This review is intended to guide researchers when selecting tests or tools for measuring treatment effects in CF trials. A consensus set of these tests and tools could improve consistency in how outcomes are captured and thereby facilitate comparisons and synthesis of evidence across studies.
Copyright ©The authors 2021.

Entities:  

Year:  2021        PMID: 33980667     DOI: 10.1183/16000617.0354-2020

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  2 in total

1.  Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review.

Authors:  Gemma E Stanford; Mandy Jones; Susan C Charman; Diana Bilton; Omar S Usmani; Jane C Davies; Nicholas J Simmonds
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

2.  Protocol for establishing a core outcome set for evaluation in studies of pulmonary exacerbations in people with cystic fibrosis.

Authors:  Charlie McLeod; Alan Robert Smyth; Mitch Messer; Andre Schultz; Jamie Wood; Richard Norman; Christopher C Blyth; Steve Webb; Zoe Elliott; Donald Van Devanter; Anne L Stephenson; Allison Tong; Thomas L Snelling
Journal:  BMJ Open       Date:  2022-09-23       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.